GT Biopharma, Inc.(GTBP)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
GT Biopharma, Inc. (GTBP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GTBP is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of GTBP by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, VANGUARD FIDUCIARY, based on the most recent SEC filings. GTBP trades on the Nasdaq exchange and files with the SEC under CIK 109657. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GTBP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GT Biopharma, Inc. directly from SEC EDGAR.
Net Income
$-4.5M
GTBP key financials by period
GT Biopharma, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2015
10-K/A
$27.0K
$-21.5M
—
FY 2014
10-K/A
$61.0K
$-23.5M
—
FY 2013
10-K
$368.0K
$-501.0K
—
FY 2012
10-K
$342.0K
$-5.2M
—
FY 2011
10-K
$26.0K
$-3.7M
—
FY 2010
10-K
$11.0K
$-3.0M
—
Institutions holding GTBP
Institutional investors reporting a position in GT Biopharma, Inc. on SEC Form 13F.
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
